Mirador Capital Partners LP Iovance Biotherapeutics, Inc. Transaction History

Mirador Capital Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $11,540 - $15,876	-1,211 Reduced 1.87%	63,479 $608,000
Q2 2022 Aug 05, 2022	BUY	$6.38 - $18.33 $137,712 - $395,653	21,585 Added 50.08%	64,690 $714,000
Q1 2022 May 06, 2022	BUY	$12.38 - $19.1 $37,622 - $58,044	3,039 Added 7.58%	43,105 $718,000
Q4 2021 Feb 02, 2022	BUY	$16.55 - $27.63 $244,476 - $408,150	14,772 Added 58.4%	40,066 $765,000
Q3 2021 Nov 09, 2021	BUY	$20.35 - $26.63 $21,082 - $27,588	1,036 Added 4.27%	25,294 $624,000
Q2 2021 Jul 27, 2021	BUY	$16.33 - $33.07 $396,133 - $802,212	24,258 New	24,258 $631,000

339

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $877M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Mirador Capital Partners LP with notifications on news.